Armand Keating, MD, FRCPC

Senior Scientist, Krembil Research Institute (Krembil)
Clinician Scientist, Princess Margaret Cancer Centre
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
https://orcid.org/0000-0002-7676-6059
Keywords: mesenchymal stromal cells (MSCs), natural killer (NK) cell, regenerative medicine, immunotherapy, cell and gene therapy, blood cancer, solid tumours, chronic degenerative diseases, clinical translation
  • Molecular signatures of high anti-inflammatory potency of stromal populations
  • Mechanisms of anti-inflammatory responses by stromal populations to treat chronic degenerative diseases, including osteoarthritis
  • Multiple cytotoxicity pathways of NK cells to eliminate cancer cells
  • Clinical translation of enhanced anti- and pro-inflammatory mechanisms to treat arthritis and cancer, respectively

For a list of Dr. Keating's publications, please visit PubMed or ORCID.


Clinician Scientist, Princess Margaret Cancer Centre
Professor of Medicine, University of Toronto
Professor, Institute of Biomedical Engineering, University of Toronto
Member, Institute of Medical Science, University of Toronto